PGC-1α promotes colorectal carcinoma metastasis through regulating ABCA1 transcription
Wei Chen,Qiushuang Zhang,Xiaoshuo Dai,Xinhuan Chen,Chengjuan Zhang,Ruihua Bai,Yihuan Chen,Kai Zhang,Xiaoxuan Duan,Yan Qiao,Jimin Zhao,Fang Tian,Kangdong Liu,Ziming Dong,Jing Lu
DOI: https://doi.org/10.1038/s41388-023-02762-y
IF: 8.756
2023-07-04
Oncogene
Abstract:Colorectal cancer (CRC) is a highly aggressive cancer in which metastasis plays a key role. However, the mechanisms underlying metastasis have not been fully elucidated. Peroxisome proliferator-activated receptor gamma coactivator 1α (PGC-1α), a regulator of mitochondrial function, has been reported as a complicated factor in cancer. In this study, we found that PGC-1α was highly expressed in CRC tissues and was positively correlated with lymph node and liver metastasis. Subsequently, PGC-1α knockdown was shown to inhibit CRC growth and metastasis in both in vitro and in vivo studies. Transcriptomic analysis revealed that PGC-1α regulated ATP-binding cassette transporter 1 (ABCA1) mediated cholesterol efflux. Mechanistically, PGC-1α interacted with YY1 to promote ABCA1 transcription, resulting in cholesterol efflux, which subsequently promoted CRC metastasis through epithelial-to-mesenchymal transition (EMT). In addition, the study identified the natural compound isoliquiritigenin (ISL) as an inhibitor that targeted ABCA1 and significantly reduced CRC metastasis induced by PGC-1α. Overall, this study sheds light on how PGC-1α promotes CRC metastasis by regulating ABCA1-mediated cholesterol efflux, providing a basis for further research to inhibit CRC metastasis.
oncology,genetics & heredity,biochemistry & molecular biology,cell biology